Tomasz M. Karpinski
Molecular Biology · 2021
A researcher in the Science corpus: 1 paper; trusts 3 researchers and is trusted by 0 researchers here, as inferred from the citation graph.
Subfields
- Molecular Biology — 26 citations into it
- Biomaterials — 20 citations into it
- Biomedical Engineering — 19 citations into it
- Cancer Research — 7 citations into it
Whom Tomasz M. Karpinski trusts overall
Their strongest outbound trust, strongest first, inferred from their citations.
Papers from Tomasz M. Karpinski's perspective
Ordered by how strongly the researchers Tomasz M. Karpinski trusts endorse each paper. Same corpus, a different order for every researcher.
- A combinatorial library of lipid-like materials for delivery of RNAi therapeutics (Nature Biotechnology)
- Membrane vesicles, current state-of-the-art: emerging role of extracellular vesicles (Cellular and Molecular Life Sciences)
- Active targeting schemes for nanoparticle systems in cancer therapeutics. (Advanced Drug Delivery Reviews)
- Pathology: Cancer cells compress intratumour vessels (Nature)
- Extracellular vesicles: Exosomes, microvesicles, and friends (Journal of Cell Biology)
- Treating metastatic cancer with nanotechnology (Nature Reviews. Cancer)
- Nanoparticle-mediated cellular response is size-dependent. (Nature Nanotechnology)
- Tumor delivery of macromolecular drugs based on the EPR effect. (Advanced Drug Delivery Reviews)
- Nanoparticle targeting of anticancer drug improves therapeutic response in animal model of human epithelial cancer. (Cancer Research)
- Cancer nanotechnology: opportunities and challenges (Nature Reviews. Cancer)
Their papers
- Nanoparticles for Cancer Therapy: Current Progress and Challenges (2021) — 805 citations